Skip to content
The Policy VaultThe Policy Vault

sofosbuvir/velpatasvirMedica

Chronic Hepatitis C Virus (HCV), genotype unknown/undetermined

Initial criteria

  • age ≥ 18 years
  • Patient does not have cirrhosis
  • Patient has not previously been treated for hepatitis C virus
  • Patient does not have hepatitis B virus
  • Patient is not pregnant
  • Patient does not have hepatocellular carcinoma
  • Patient has not had a liver transplantation
  • Prescribed by or in consultation with a gastroenterologist, hepatologist, infectious diseases physician, or liver transplant physician

Approval duration

12 weeks